Feng‐Di T. Lung

904 total citations
27 papers, 777 citations indexed

About

Feng‐Di T. Lung is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Feng‐Di T. Lung has authored 27 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Feng‐Di T. Lung's work include Chemical Synthesis and Analysis (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Feng‐Di T. Lung is often cited by papers focused on Chemical Synthesis and Analysis (9 papers), Protein Kinase Regulation and GTPase Signaling (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Feng‐Di T. Lung collaborates with scholars based in Taiwan, United States and China. Feng‐Di T. Lung's co-authors include Peter P. Roller, Albert J. Fornace, Byeong Jae Lee, Dolph L. Hatfield, William S. Lane, Harold S. Chittum, Bradley A. Carlson, O.I. Kovalsky, C. Richter King and Peter L. Nara and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Feng‐Di T. Lung

27 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng‐Di T. Lung Taiwan 15 617 204 81 81 74 27 777
Janelle L. Harris Australia 9 720 1.2× 202 1.0× 69 0.9× 48 0.6× 45 0.6× 12 919
Kerstin K. Leuther United States 13 928 1.5× 130 0.6× 84 1.0× 69 0.9× 75 1.0× 19 1.2k
Vered Bronner Israel 9 564 0.9× 146 0.7× 94 1.2× 53 0.7× 92 1.2× 11 690
Erhard Kopetzki Germany 21 574 0.9× 120 0.6× 88 1.1× 98 1.2× 68 0.9× 29 1.1k
Chantal Illy France 9 415 0.7× 129 0.6× 55 0.7× 88 1.1× 66 0.9× 11 644
Mhairi Skinner Canada 10 551 0.9× 160 0.8× 73 0.9× 119 1.5× 158 2.1× 28 888
Fu‐Tong Liu United States 9 430 0.7× 63 0.3× 128 1.6× 120 1.5× 48 0.6× 10 721
F. Molemans Belgium 10 1.0k 1.7× 95 0.5× 67 0.8× 105 1.3× 127 1.7× 13 1.3k
Vincent Brondani Switzerland 12 1.0k 1.7× 122 0.6× 24 0.3× 96 1.2× 49 0.7× 17 1.2k
Pi-Wan Cheng United States 19 666 1.1× 99 0.5× 50 0.6× 179 2.2× 197 2.7× 32 893

Countries citing papers authored by Feng‐Di T. Lung

Since Specialization
Citations

This map shows the geographic impact of Feng‐Di T. Lung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng‐Di T. Lung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng‐Di T. Lung more than expected).

Fields of papers citing papers by Feng‐Di T. Lung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng‐Di T. Lung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng‐Di T. Lung. The network helps show where Feng‐Di T. Lung may publish in the future.

Co-authorship network of co-authors of Feng‐Di T. Lung

This figure shows the co-authorship network connecting the top 25 collaborators of Feng‐Di T. Lung. A scholar is included among the top collaborators of Feng‐Di T. Lung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng‐Di T. Lung. Feng‐Di T. Lung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsiao, Yu‐Cheng, et al.. (2013). Anticancer activities of an antimicrobial peptide derivative of Ixosin-B amide. Bioorganic & Medicinal Chemistry Letters. 23(20). 5744–5747. 14 indexed citations
2.
Wu, Yu‐Shan, et al.. (2013). Structure–activity relationship of potent antimicrobial peptide analogs of Ixosin-B amide. Bioorganic & Medicinal Chemistry Letters. 23(10). 2929–2932. 4 indexed citations
3.
Lung, Feng‐Di T., et al.. (2012). Discovery of potent antimicrobial peptide analogs of Ixosin-B. Bioorganic & Medicinal Chemistry Letters. 22(12). 4185–4188. 14 indexed citations
4.
Yang, Shih‐ying, et al.. (2011). Structure–activity relationships of a peptidic antagonist of Id1 studied by biosensor method, circular dichroism spectroscopy, and bioassay. Journal of Peptide Science. 17(10). 667–674. 2 indexed citations
5.
Kuo, Sheng‐Chu, et al.. (2010). Affinity of synthetic peptide fragments of MyoD for Id1 protein and their biological effects in several cancer cells. Journal of Peptide Science. 16(5). 231–241. 15 indexed citations
6.
Jeng, Kee-Ching, et al.. (2009). Effects of Peptidic Antagonists of Grb2-SH2 on Human Breast Cancer Cells. Protein and Peptide Letters. 17(1). 44–53. 9 indexed citations
7.
Lung, Feng‐Di T., et al.. (2008). Determination of Binding Potency of Peptidic Inhibitors of Grb2-SH2 by Using the Protein-Captured Biosensor Method. Protein and Peptide Letters. 15(8). 806–810. 2 indexed citations
8.
Lung, Feng‐Di T., Chiung‐Wen Chang, Peng Li, et al.. (2005). Small nonphosphorylated Grb2–SH2 domain antagonists evaluated by surface plasmon resonance technology. Biopolymers. 80(5). 628–635. 7 indexed citations
9.
Chen, Hao‐Ping, et al.. (2003). The role of the conserved histidine-aspartate pair in the ‘base-off’ binding of cobalamins. Bioorganic & Medicinal Chemistry. 12(3). 577–582. 5 indexed citations
10.
Lung, Feng‐Di T., et al.. (2003). Grb2 SH2 domain‐binding peptide analogs as potential anticancer agents. Biopolymers. 71(2). 132–140. 16 indexed citations
11.
Long, Ya‐Qiu, Feng‐Di T. Lung, & Peter P. Roller. (2003). Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain. Bioorganic & Medicinal Chemistry. 11(18). 3929–3936. 16 indexed citations
12.
Lung, Feng‐Di T., et al.. (2002). Binding Potency of Peptide Fragments of Type 1 Collagen Cross-Linked N Telopeptide Measured by an Enzyme-Linked Immunosorbant Assay. Protein and Peptide Letters. 9(5). 451–457. 2 indexed citations
13.
Kovalsky, O.I., Feng‐Di T. Lung, Peter P. Roller, & Albert J. Fornace. (2001). Oligomerization of Human Gadd45a Protein. Journal of Biological Chemistry. 276(42). 39330–39339. 68 indexed citations
14.
Tzeng, Shiou‐Ru, Chih‐Wei Wu, Jya‐Wei Cheng, et al.. (2000). Stability and peptide binding specificity of Btk SH2 domain: Molecular basis for X‐linked agammaglobulinemia. Protein Science. 9(12). 2377–2385. 31 indexed citations
15.
Zhao, Hongcheng, Shunqian Jin, Michael J. Antinore, et al.. (2000). The Central Region of Gadd45 Is Required for Its Interaction with p21/WAF1. Experimental Cell Research. 258(1). 92–100. 58 indexed citations
16.
Lung, Feng‐Di T., C. Richter King, & Peter P. Roller. (1999). Development of non-phosphorylated cyclic thioether peptide binding to the Grb2-SH2 domain. International Journal of Peptide Research and Therapeutics. 6(1). 45–49. 22 indexed citations
17.
Lou, Yuan‐Chao, et al.. (1999). Solution Structure and Dynamics of G1TE, a Nonphosphorylated Cyclic Peptide Inhibitor for the Grb2 SH2 Domain. Archives of Biochemistry and Biophysics. 372(2). 309–314. 14 indexed citations
18.
Chittum, Harold S., William S. Lane, Bradley A. Carlson, et al.. (1998). Rabbit β-Globin Is Extended Beyond Its UGA Stop Codon by Multiple Suppressions and Translational Reading Gaps. Biochemistry. 37(31). 10866–10870. 190 indexed citations
19.
Lung, Feng‐Di T., Lakshmi Sastry, James C. Bigelow, et al.. (1997). Nonphosphorylated Peptide Ligands for the Grb2 Src Homology 2 Domain. Journal of Biological Chemistry. 272(46). 29046–29052. 90 indexed citations
20.
Lung, Feng‐Di T., Jean‐Philippe Meyer, Bih‐Show Lou, et al.. (1996). Effects of Modifications of Residues in Position 3 of Dynorphin A(1−11)-NH2on κ Receptor Selectivity and Potency. Journal of Medicinal Chemistry. 39(13). 2456–2460. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janelle L. Harris Breakdown of academic impact, for papers by Kerstin K. Leuther Breakdown of academic impact, for papers by Vered Bronner Breakdown of academic impact, for papers by Erhard Kopetzki Breakdown of academic impact, for papers by Chantal Illy Breakdown of academic impact, for papers by Mhairi Skinner Breakdown of academic impact, for papers by Fu‐Tong Liu Breakdown of academic impact, for papers by F. Molemans Breakdown of academic impact, for papers by Vincent Brondani Breakdown of academic impact, for papers by Pi-Wan Cheng
Rankless by CCL
2026